Journey Medical Corporation (DERM)

Company Overview

Journey Medical is focused on strategically identifying, acquiring, and successfully commercializing innovative and differentiated dermatology products. The Journey team is comprised of industry experts with decades of experience commercializing some of the most successful prescription dermatology brands. Our market knowledge and experience allow us to identify undervalued assets and future opportunities, then commercialize these opportunities through a best-in-dermatology marketing and sales organization.

Download Presentation View Management Team

Latest News

Dec 6, 2023 • 8:00am EST

Journey Medical Corporation Announces Successful Completion of Pre-NDA Meeting with the FDA for DFD-29 to Treat Rosacea

Read Press Release

Nov 7, 2023 • 4:01pm EST

Journey Medical Corporation Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights

Oct 31, 2023 • 8:30am EDT

Journey Medical Corporation to Announce Third Quarter 2023 Financial Results on November 7, 2023

Oct 20, 2023 • 8:30am EDT

Journey Medical Corporation Announces Data from Bioavailability Study of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) vs. Solodyn® (Minocycline Hydrochloride Extended-Release Tablets, 105 mg)

View All SEC Filings

Q3 2023

Quarter Ended Sep 30, 2023

Earnings Release

Audio

Earnings Webcast

10-Q

PDF HTML

XBRL

ZIP XLS HTML

Latest Annual Filing

For Fiscal Year Ending Dec 31, 2022

Contacts

Corporate

Journey Medical Corporation
9237 East Via De Ventura
Suite 105
Scottsdale, AZ 85258
T: 480-434-6670
contact@jmcderm.com

Investor Relations

Jaclyn Jaffe
T: 781-652-4500
ir@jmcderm.com

Transfer Agent

VStock Transfer
Allison Niccolls
allison@vstocktransfer.com